| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2024 ( Subtotal = $0 ) |
| | 2024 | 2023 | I-CORDIS, LLC | 312 OVERHILL RD | BALTIMORE | MD | 21210-2906 | BALTIMORE CITY | USA | R44HL145833 | Development of a Novel Immunomodulatory Pyridone for the Treatment of Heart Failure with Preserved Ejection Fraction | 000 | 3 | NIH | 10/11/2023 | $0 |
|
| Issue Date FY: 2023 ( Subtotal = $739,896 ) |
| | 2023 | 2023 | I-CORDIS, LLC | 312 OVERHILL RD | BALTIMORE | MD | 21210-2906 | BALTIMORE CITY | USA | R44HL145833 | Development of a Novel Immunomodulatory Pyridone for the Treatment of Heart Failure with Preserved Ejection Fraction | 000 | 3 | NIH | 8/8/2023 | $739,896 |
| | 2023 | 2019 | I-CORDIS, LLC | 312 OVERHILL RD | BALTIMORE | MD | 21210-2906 | BALTIMORE CITY | USA | R43HL145833 | Development of a novel immunomodulatory pyridone for the treatment of acute heart damage | 000 | 1 | NIH | 9/12/2023 | $0 |
|
| Issue Date FY: 2022 ( Subtotal = $808,812 ) |
| | 2022 | 2022 | I-CORDIS, LLC | 4362 W PINE BLVD | SAINT LOUIS | MO | 63108-2206 | SAINT LOUIS CITY | USA | R44HL145833 | Development of a Novel Immunomodulatory Pyridone for the Treatment of Heart Failure with Preserved Ejection Fraction | 000 | 2 | NIH | 8/2/2022 | $808,812 |
|
| Issue Date FY: 2021 ( Subtotal = $0 ) |
| | 2021 | 2019 | I-CORDIS, LLC | 4362 W PINE BLVD | SAINT LOUIS | MO | 63108-2206 | SAINT LOUIS CITY | USA | R43HL145833 | Development of a novel immunomodulatory pyridone for the treatment of acute heart damage | 000 | 1 | NIH | 8/29/2021 | $0 |
|
| Issue Date FY: 2020 ( Subtotal = $0 ) |
| | 2020 | 2019 | I-CORDIS, LLC | 4362 W PINE BLVD | SAINT LOUIS | MO | 63108-2206 | SAINT LOUIS CITY | USA | R43HL145833 | Development of a novel immunomodulatory pyridone for the treatment of acute heart damage | 000 | 1 | NIH | 11/6/2019 | $0 |
| | 2020 | 2019 | I-CORDIS, LLC | 4362 W PINE BLVD | SAINT LOUIS | MO | 63108-2206 | SAINT LOUIS CITY | USA | R43HL145833 | Development of a novel immunomodulatory pyridone for the treatment of acute heart damage | 001 | 1 | NIH | 9/5/2020 | $0 |
|
| Issue Date FY: 2019 ( Subtotal = $276,227 ) |
| | 2019 | 2019 | I-CORDIS, LLC | 4362 W PINE BLVD | SAINT LOUIS | MO | 63108-2206 | SAINT LOUIS CITY | USA | R43HL145833 | Development of a novel immunomodulatory pyridone for the treatment of acute heart damage | 000 | 1 | NIH | 9/18/2019 | $276,227 |
|
|
